Epidemiology of respiratory syncytial virus in children ≤2 years of age hospitalized with lower respiratory tract infections in the Russian Federation: A prospective, multicenter study

Clinical Epidemiology

Volumn 2, Issue 1, 2010, Pages 221-227

  Tatochenko, Vladimir ^a   Uchaikin, Vasily ^b   Gorelov, Aleksandr ^c   Gudkov, Konstantin ^d   Campbell, Andrew ^d   Schulz, Gregory ^d   Prahl, Rebecca ^d   Notario, Gerard ^d  

^a Russian Academy of Medical Sciences   (Russian Federation)

^b PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^c CENTRAL RESEARCH INSTITUTE OF EPIDEMIOLOGY   (Russian Federation)

^d ABBOTT LABORATORIES   (United States)

Author keywords

Palivizumab; Prevalence; Prophylaxis; RSV; Seasonality

Indexed keywords

AGE; ARTICLE; ARTIFICIAL VENTILATION; BODY HEIGHT; BODY TEMPERATURE; BODY WEIGHT; BREAST FEEDING; BREATHING RATE; CHILD; CHILD HOSPITALIZATION; CHROMATOGRAPHY; CHRONIC LUNG DISEASE; CLINICAL EVALUATION; CONGENITAL HEART DISEASE; DAY CARE; FAMILY HISTORY; FEMALE; FURRED PET ANIMAL; GEOGRAPHIC DISTRIBUTION; HEART RATE; HIGH RISK PATIENT; HOUSEHOLD; HUMAN; LENGTH OF STAY; LOWER RESPIRATORY TRACT INFECTION; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MATERNAL SMOKING; MEDICAL HISTORY; MORBIDITY; MORTALITY; NASOPHARYNGEAL LAVAGE; NASOPHARYNX; NORTHERN HEMISPHERE; OXYGEN SATURATION; OXYGENATION; PASSIVE SMOKING; PET ANIMAL; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PRESCHOOL CHILD; PREVALENCE; PROSPECTIVE STUDY; RAPID IMMUNOCHROMATOGRAPHY; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RISK FACTOR; RUSSIAN FEDERATION; SEASONAL VARIATION; SIBLING; SOCIAL ASPECT; VITAL SIGN;

EID: 78650693406     PISSN: None     EISSN: 11791349     Source Type: Book Series    
DOI: 10.2147/CLEP.S12279     Document Type: Article

References (32)

1. Kimpen JL, Simoes EA. Respiratory syncytial virus and reactive airway disease. New developments prompt a new review. Am J Respir Crit Care Med. 2001;163(3 Pt 2):S1.
2. Ogra PL. Respiratory syncytial virus: the virus, the disease and the immune response. Paediatr Respir Rev. 2004;5(Suppl A):S119-S126.
3. Garenne M, Ronsmans C, Campbell H. The magnitude of mortality from acute respiratory infections in children under 5 years in developing countries. World Health Stat Q. 1992;45(2-3):180-191.
4. Trinstram DA, Welliver RC. Respiratory syncytial virus. In: Long SS, Pickering LK, Prober CG, editors. Principles and Practice of Pediatric Infectious Diseases. St. Louis, MO: Elsevier; 2003:1140-1148.
5. Stensballe LG, Devasundaram JK, Simoes EA. Respiratory syncytial virus epidemics: the ups and downs of a seasonal virus. Pediatr Infect Dis J. 2003;22 Suppl 2:S21-S32.
6. Centers for Disease Control and Prevention. Respiratory syncytial virus activity - United States, 1999-2000 season. MMWR Morb Mortal Wkly Rep. 2000;49(48):1091-1093.
7. Hall CB, Douglas RG Jr, Schnabel KC, Geiman JM. Infectivity of respiratory syncytial virus by various routes of inoculation. Infect Immun. 1981;33(3):779-783.
8. Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child. 1986;140(6):543-546.
9. Everard M. Diagnosis, admission, discharge. Paediatr Respir Rev. 2009;10(Suppl 1):S18-S20.
10. Handforth J, Sharland M, Friedland JS. Prevention of respiratory syncytial virus infection in infants. BMJ. 2004;328(7447):1026-1027.
11. The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics. 1998;102(3 Pt 1):531-537.
12. Feltes TF, Cabalka AK, Meissner HC, et al. Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. J Pediatr. 2003;143(4):532-540.
13. Mlinaric-Galinovic G, Ugrcic I, Detic D, Bozikov J. Epidemiological picture of respiratory viral infections in Croatia. Acta Med Iugosl. 1991;45(3):203-211.
14. Piippo-Savolainen E, Korppi M, Korhonen K, Remes S. Adult asthma after non-respiratory syncytial virus bronchiolitis in infancy: subgroup analysis of the 20-year prospective follow-up study. Pediatr Int. 2007;49(2):190-195.
15. Terletskaia-Ladwig E, Enders G, Schalasta G, Enders M. Defining the timing of respiratory syncytial virus (RSV) outbreaks: an epidemiological study. BMC Infect Dis. 2005;5(1):20.
16. Larcher C, Jeller V, Fischer H, Huemer HP. Prevalence of respiratory viruses, including newly identified viruses, in hospitalised children in Austria. Eur J Clin Microbiol Infect Dis. 2006;25(11):681-686.
17. Fjaerli HO, Farstad T, Bratlid D. Hospitalisations for respiratory syncytial virus bronchiolitis in Akershus, Norway, 1993-2000: a populationbased retrospective study. BMC Pediatr. 2004;4(1):25.
18. Simoes EA, Carbonell-Estrany X. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries. Pediatr Infect Dis J. 2003;22(Suppl 2):S13-S18; discussion S18-S20.
19. Law BJ, Carbonell-Estrany X, Simoes EA. An update on respiratory syncytial virus epidemiology: a developed country perspective. Respir Med. 2002;96(Suppl B):S1-S7.
20. Berner R, Schwoerer F, Schumacher RF, Meder M, Forster J. Community and nosocomially acquired respiratory syncytial virus infection in a German paediatric hospital from 1988 to 1999. Eur J Pediatr. 2001;160(9):541-547.
21. Mlinaric-Galinovic G, Welliver RC, Vilibic-Cavlek T, et al. The biennial cycle of respiratory syncytial virus outbreaks in Croatia. Virol J. 2008;5:18.
22. Weigl JA, Puppe W, Schmitt HJ. Incidence of respiratory syncytial virus-positive hospitalizations in Germany. Eur J Clin Microbiol Infect Dis. 2001;20(7):452-459.
23. Weigl JA, Puppe W, Schmitt HJ. Seasonality of respiratory syncytial virus-positive hospitalizations in children in Kiel, Germany, over a 7-year period. Infection. 2002;30(4):186-192.
24. Kanra G, Tezcan S, Yilmaz G. Respiratory syncytial virus epidemiology in Turkey. Turk J Pediatr. 2005;47(4):303-308.
25. Kristensen K, Dahm T, Frederiksen PS, et al. Epidemiology of respiratory syncytial virus infection requiring hospitalization in East Denmark. Pediatr Infect Dis J. 1998;17(11):996-1000.
26. NASA. 2008-2009 Winter Land Surface Temperature Anomalies. Greenbelt, Maryland: NASA Earth Observatory [updated 2009 May 9]. Available from http://earthobservatory.nasa.gov/IOTD/view.php?idpp38419.
27. McCormick J, Tubman R. Readmission with respiratory syncytial virus (RSV) infection among graduates from a neonatal intensive care unit. Pediatr Pulmonol. 2002;34(4):262-266.
28. Medici MC, Arcangeletti MC, Merolla R, Chezzi C. Incidence of respiratory syncytial virus infection in infants and young children referred to the emergency departments for lower respiratory tract diseases in Italy. Acta Biomed. 2004;75(1):26-33.
29. Sarasini A, Percivalle E, Rovida F, et al. Detection and pathogenicity of human metapneumovirus respiratory infection in pediatric Italian patients during a winter - spring season. J Clin Virol. 2006;35(1):59-68.
30. Simoes EA, Groothuis JR. Respiratory syncytial virus prophylaxis - the story so far. Respir Med. 2002;96(Suppl B):S15-S24.
31. Figueras-Aloy J, Carbonell-Estrany X, Quero J. Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33-35 weeks in Spain. Pediatr Infect Dis J. 2004;23(9):815-820.
32. Law BJ, Langley JM, Allen U, et al. The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation. Pediatr Infect Dis J. 2004;23(9):806-814.